The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer

Author:

Trotman JamieORCID,Armstrong Ruth,Firth Helen,Trayers Claire,Watkins James,Allinson KierenORCID,Jacques Thomas S.,Nicholson James C.,Burke G. A. AmosORCID,Ambrose J. C.,Arumugam P.,Bevers R.,Bleda M.,Boardman-Pretty F.,Boustred C. R.,Brittain H.,Caulfield M. J.,Chan G. C.,Fowler T.,Giess A.,Hamblin A.,Henderson S.,Hubbard T. J. P.,Jackson R.,Jones L. J.,Kasperaviciute D.,Kayikci M.,Kousathanas A.,Lahnstein L.,Leigh S. E. A.,Leong I. U. S.,Lopez F. J.,Maleady-Crowe F.,McEntagart M.,Minneci F.,Moutsianas L.,Mueller M.,Murugaesu N.,Need A. C.,O‘Donovan P.,Odhams C. A.,Patch C.,Perez-Gil D.,Pereira M. B.,Pullinger J.,Rahim T.,Rendon A.,Rogers T.,Savage K.,Sawant K.,Scott R. H.,Siddiq A.,Sieghart A.,Smith S. C.,Sosinsky A.,Stuckey A.,Tanguy M.,Taylor Tavares A. L.,Thomas E. R. A.,Thompson S. R.,Tucci A.,Welland M. J.,Williams E.,Witkowska K.,Wood S. M.,Behjati Sam,Murray Matthew J.,Hook Catherine E.,Tarpey PatrickORCID,

Abstract

Abstract Background Whole-genome sequencing (WGS) of cancers is becoming an accepted component of oncological care, and NHS England is currently rolling out WGS for all children with cancer. This approach was piloted during the 100,000 genomes (100 K) project. Here we share the experience of the East of England Genomic Medicine Centre (East-GMC), reporting the feasibility and clinical utility of centralised WGS for individual children locally. Methods Non-consecutive children with solid tumours were recruited into the pilot 100 K project at our Genomic Medicine Centre. Variant catalogues were returned for local scrutiny and appraisal at dedicated genomic tumour advisory boards with an emphasis on a detailed exploration of potential clinical value. Results Thirty-six children, representing one-sixth of the national 100 K cohort, were recruited through our Genomic Medicine Centre. The diagnoses encompassed 23 different solid tumour types and WGS provided clinical utility, beyond standard-of-care assays, by refining (2/36) or changing (4/36) diagnoses, providing prognostic information (8/36), defining pathogenic germline mutations (1/36) or revealing novel therapeutic opportunities (8/36). Conclusion Our findings demonstrate the feasibility and clinical value of centralised WGS for children with cancer. WGS offered additional clinical value, especially in diagnostic terms. However, our experience highlights the need for local expertise in scrutinising and clinically interpreting centrally derived variant calls for individual children.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3